MHRA approves zanidatamab (Ziihera) for the treatment of biliary tract cancer
seen at 15:41, 19 February in News and communications.MHRA approves zanidatamab (Ziihera) for the treatment of biliary tract cancer
seen at 15:41, 19 February in News and communications.